Poly ICLC
Jump to navigation
Jump to search
| Gene therapy | |
|---|---|
| Clinical data | |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| Chemical and physical data | |
Poly ICLC is an immunostimulant.
It consists of carboxymethylcellulose, polyinosinic-polycytidylic acid, and poly-L-lysine double-stranded RNA.[1]
It is a ligand for toll like receptor-3.[2]
References
- ↑ "Definition of poly ICLC - National Cancer Institute Drug Dictionary". Retrieved 2007-11-13.
- ↑ Zhu X, Nishimura F, Sasaki K; et al. (2007). "Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models". Journal of translational medicine. 5: 10. doi:10.1186/1479-5876-5-10. PMID 17295916.
http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=39559
Categories:
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
- Articles with short description
- Infobox drug articles without a structure image
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes